DPF2

Information DPF2

Description

The protein encoded by this gene is a member of the d4 domain family, characterized by a zinc finger-like structural motif. This protein functions as a transcription factor which is necessary for the apoptotic response following deprivation of survival factors. It likely serves a regulatory role in rapid hematopoietic cell growth and turnover. This gene is considered a candidate gene for multiple endocrine neoplasia type I, an inherited cancer syndrome involving multiple parathyroid, enteropancreatic, and pituitary tumors. [provided by RefSeq, Jul 2008]

Full Name

double PHD fingers 2

Source NCBI

ReMap Statistics

Datasets
4
Biotypes
3
Peaks
220,016
Non-redundant peaks
164,955

TF Classification

Super Class
Unknown
Class
Unknown
Familly
Unknown
Sub Familly
Unknown

Source TFClass

External IDs

JASPAR
Ensembl
ENSG00000133884
UniProt
Q92785
Genevisible
Q92785
RefSeq
NM_001330308
Aliases
BAF45d; CSS7; REQ; UBID4; ubi-d4
All peaks DPF2
Download BED file
Non redundant peaks DPF2
Download BED file
SEQUENCES DPF2
Download FASTA file
DOWNLOAD All ReMap
Got to catalogue

Datasets Table for DPF2

Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks
DPF2 GM12878 ENCODE Homo sapiens ENCSR509FWH 56,816
DPF2 K-562 ENCODE Homo sapiens ENCSR219BXP 42,973
DPF2 K-562 ENCODE Homo sapiens ENCSR715CCR 86,114
DPF2 MCF-7 ENCODE Homo sapiens ENCSR234VCE 34,113
Target name Target modification Ecotype/Strain Biotype Biotype modification Source Species Experiment Peaks

ReMap is a database of transcriptional regulators peaks derived from curated ChIP-seq, ChIP-exo, DAP-seq experiments in Human and Thaliana.

You are using the 2020 ReMap (3rd) release.
The ReMap catalogues (2020, 2018, 2015) are under CC BY-NC 4.0 international license, while ReMapEnrich, remap-pipeline under GNU GPLv3 licence.

Inserm TAGC
AMU AMU-MESO

This work was granted access to the HPC resources of Aix-Marseille Université financed by the project Equip@Meso (ANR-10-EQPX-29-01) of the program "Investissements d’Avenir" supervised by the Agence Nationale de la Recherche.